Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.1940 +0.0011 (+0.57%)
Delayed Quote Updated: 3:49 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares
Via AB Newswire
Topics Artificial Intelligence
News headline image
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) CEO Discusses Commercial Graphene Growth and Global Expansion Watch Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates
Via AB Newswire
Topics Artificial Intelligence
News headline image
MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug Discovery
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
From New to The Street
Via ACCESS Newswire
News headline image
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE American: IGC) Alzheimer’s Drug Gains Attention After Ascendiant Capital Raises Price Target
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis
Via ACCESS Newswire
News headline image
Kartoon Studios (NYSE: TOON) After Hours SURGE on $28.5M Legal Settlement – Momentum Just Beginning See Why
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts
Via ACCESS Newswire
News headline image
American Lithium Minerals (OTC: AMLM) Advances Strategy to Unlock Value From Quebec Polymetallic Assets – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
The Mag Microcaps: BCDA, PRSO, IGC, SMTK, SNBR Under $1 in Focus More Catalysts Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Listed NanoCaps: PMI, IGC, WTC, WOK, SELX Radar Stocks to Watch Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis
Via ACCESS Newswire
News headline image
IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities
Via ACCESS Newswire
News headline image
Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, and Global Workforce Technology
Via ACCESS Newswire
News headline image
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment
Via ACCESS Newswire
News headline image
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma
Via ACCESS Newswire
News headline image
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference
Via ACCESS Newswire
News headline image
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
Via ACCESS Newswire
News headline image
GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
Via ACCESS Newswire
News headline image
IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase
Via ACCESS Newswire
News headline image
New to The Street to Air Show #747 Tonight on Fox Business Network Featuring Performance Golf, CitroTech, Lee Gause, CISO Global, and Lost Soldier Oil and Gas
Via ACCESS Newswire
News headline image
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
Via ACCESS Newswire
News headline image
IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.